Fresenius Medical Care Jersey City, LLC
Fresenius Medical Care Jersey City, LLC was paid $8.04M by Medicaid between Jun 2018 and Nov 2024, across 54 billing codes. Its largest line is 90999, dialysis (unlisted procedure) — 48% of everything it billed.
JERSEY CITY, NJ 07304
Next to other End-Stage Renal Disease (ESRD) Treatment Clinic/Center providers in New Jersey
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,543 | $478K | |
| 2019 | 30,717 | $1.69M | |
| 2020 | 36,361 | $1.49M | |
| 2021 | 35,917 | $1.29M | |
| 2022 | 84,094 | $1.38M | |
| 2023 | 105,427 | $1.21M | |
| 2024incomplete | 75,875 | $510K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90999 | Dialysis (unlisted procedure)Unlisted dialysis procedure, inpatient or outpatient | 48% | 54,053 | 4,190 | $3.88M |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 41% | 25,343 | 2,110 | $3.33M |
| 85018 | 1.1% | 15,120 | 3,979 | $92K | |
| A4657 | Syringe, with or without needle, each | 1.1% | 69,719 | 4,507 | $91K |
| 84520 | 1.0% | 9,311 | 3,935 | $81K | |
| 84100 | <1% | 8,158 | 3,897 | $67K | |
| 82310 | <1% | 6,839 | 3,830 | $63K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 15,738 | 2,943 | $43K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | <1% | 6,500 | 3,042 | $36K |
| 83970 | <1% | 4,932 | 3,825 | $35K | |
| 83540 | <1% | 5,014 | 3,902 | $33K | |
| 84460 | <1% | 4,414 | 3,457 | $30K |
42 more codes
| 82040 | <1% | 3,225 | $27K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | <1% | 5,353 | $27K |
| 82565 | <1% | 3,248 | $26K | |
| 80051 | <1% | 3,048 | $25K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,003 | $24K |
| 87340 | <1% | 3,175 | $19K | |
| 84466 | <1% | 492 | $18K | |
| 83550 | <1% | 4,442 | $15K | |
| 82728 | <1% | 1,960 | $13K | |
| 84155 | <1% | 4,213 | $12K | |
| 84075 | <1% | 1,104 | $10K | |
| 84450 | <1% | 1,338 | $10K | |
| 82247 | <1% | 967 | $10K | |
| 82108 | <1% | 653 | $7K | |
| 83735 | <1% | 1,434 | $5K | |
| 82746 | <1% | 294 | $4K | |
| 86706 | <1% | 655 | $3K | |
| 80069 | <1% | 1,098 | $2K | |
| G0008 | Administration of influenza virus vaccine | <1% | 341 | $2K |
| 80053 | Comprehensive metabolic panel | <1% | 414 | $1K |
| 90688 | <1% | 50 | $803.28 | |
| 84132 | <1% | 802 | $306.45 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 41,862 | $171.63 |
| OP250 | <1% | 64,335 | $80.87 | |
| 90662 | <1% | 65 | $12.20 | |
| 86704 | <1% | 21 | $2.12 | |
| 85046 | <1% | 234 | $1.32 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 411 | $0.00 |
| 0001A | 0% | 20 | $0.00 | |
| 0064A | 0% | 21 | $0.00 | |
| 90686 | 0% | 95 | $0.00 | |
| 90732 | 0% | 14 | $0.00 | |
| 86803 | 0% | 368 | $0.00 | |
| 90673 | 0% | 20 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 0% | 14 | $0.00 |
| J3490 | Unclassified drugs | 0% | 34 | $0.00 |
| J1270 | Injection, doxercalciferol, 1 mcg | 0% | 301 | $0.00 |
| A6216 | Gauze, non-impregnated, non-sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | 0% | 8,217 | $0.00 |
| 82947 | 0% | 341 | $0.00 | |
| 0002A | 0% | 15 | $0.00 | |
| 90682 | 0% | 73 | $0.00 | |
| 90661 | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.